Indeed, in accordance with a suggested therapeutic role for IL-4Rα/basophil signaling in our present studies, recent clinical data from a single small study have suggested an increase in basophils associated with conjunctivitis in patients with AD following dupilumab treatment (17). Here, IL4R is linked to conjunctivitis.